Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Cheng Ting Hsu"'
Autor:
Po‐Yao Hsu, Tzu‐Sheng Cheng, Shih‐Chang Chuang, Wen‐Tsan Chang, Po‐Cheng Liang, Cheng‐Ting Hsu, Yu‐Ju Wei, Tyng‐Yuan Jang, Ming‐Lun Yeh, Ching‐I Huang, Yi‐Hung Lin, Chih‐Wen Wang, Ming‐Yen Hsieh, Nai‐Jen Hou, Meng‐Hsuan Hsieh, Yi‐Shan Tsai, Yu‐Min Ko, Ching‐Chih Lin, Kuan‐Yu Chen, Chia‐Yen Dai, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Wan‐Long Chuang, Chung‐Feng Huang, Ming‐Lung Yu
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 104-116 (2022)
Abstract Background and Aims Regorafenib has demonstrated its survival benefit for unresectable hepatocellular carcinoma (uHCC) patients in a phase III clinical trial. We aimed to assess the efficacy and tolerability of regorafenib and the predictors
Externí odkaz:
https://doaj.org/article/8169183efd244c82bda9348fe3369e9a
Autor:
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, Pei-Chien Tsai, Meng-Hsuan Hsieh, Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Wen-Yu Chang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The spreading of viral hepatitis among injecting drug users (IDU) is an emerging public health concern. This study explored the prevalence and the risks of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) among ID
Externí odkaz:
https://doaj.org/article/328c875a407843f19a3d838d8a4b54fd
Autor:
Tyng-Yuan Jang, Yu-Ju Wei, Ta-Wei Liu, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I. Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Hepatitis D virus (HDV) infection increases the risk of hepatocellular carcinoma (HCC) in the natural course of chronic hepatitis B (CHB) patients. Its role in patients treated with nucleotide/nucleoside analogues (NAs) is unclear. We aimed
Externí odkaz:
https://doaj.org/article/df70726873da4e8aa1cc719caa2ada9b
Autor:
Cheng Ting Hsu, 徐振庭
95
This thesis is composed of two important parts. (1) The application of scanning probe lithography (SPL) to achieve selectively deposition of AuNPs on the silicon oxide (SiO2). (2)The electrical characteristics of the nonvolatile nanoparticle
This thesis is composed of two important parts. (1) The application of scanning probe lithography (SPL) to achieve selectively deposition of AuNPs on the silicon oxide (SiO2). (2)The electrical characteristics of the nonvolatile nanoparticle
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/80231013802975411471
Autor:
Tyng-Yuan Jang, Yu-Ju Wei, Ming-Lun Yeh, Shu-Fen Liu, Cheng-Ting Hsu, Po-Yao Hsu, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Meng-Hsuan Hsieh, Yu-Min Ko, Yi-Shan Tsai, Kuan-Yu Chen, Ching-Chih Lin, Pei-Chien Tsai, Shu-Chi Wang, Ching-I. Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 1, Pp 303-310 (2021)
Background: The biochemical response is a crucial indicator of prognosis in chronic hepatitis B (CHB) patients treated with nucleotide/nucleoside analogues (NAs). The impact of hepatitis D virus (HDV) infection on alanine aminotransferase normalizati
Externí odkaz:
https://doaj.org/article/bab2a77580f042e6aee24df2353d343d
Autor:
Chung-Feng Huang, Pey-Fang Wu, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Cheng-Ting Hsu, Po-Yao Hsu, Hung-Yin Liu, Ying-Chou Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Publikováno v:
Clinical and Molecular Hepatology, Vol 27, Iss 1, Pp 136-143 (2021)
Background/Aims Obstacles exist in facilitating hepatitis C virus (HCV) care cascade. To increase timely and accurate diagnosis, disease awareness and accessibility, in-hospital HCV reflex testing followed by automatic appointments and a late call-ba
Externí odkaz:
https://doaj.org/article/503e889aa7774063895afe9c7d4bb1b4
Autor:
Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu
Publikováno v:
Clinical and Molecular Hepatology, Vol 27, Iss 1, Pp 186-196 (2021)
Background/Aims Direct‐acting antivirals (DAAs) have been approved for hepatitis C virus (HCV) treatment in patients with end-stage renal disease (ESRD) on hemodialysis. Nevertheless, the complicated comedications and their potential drug-drug inte
Externí odkaz:
https://doaj.org/article/d7924f2b4a934b40943697e7cf109b9d
Autor:
Shiu-Feng Huang, Yhu-Chering Huang, Feng-Yee Chang, Jung-Chung Lin, Chun-Hsiang Chiu, Chien-Wen Chen, Fu-Der Wang, Yen-Ling Chiu, Shu-Hsing Cheng, Chien-Yu Cheng, Yi-Chun Lin, Cheng-Pin Chen, Chien-Hsien Huang, Po-Yu Liu, Yuan-Ti Lee, Chen-Hsiang Lee, Yao-Shen Chen, Cheng-Len Sy, Yu-Ting Tseng, Cheng-Ting Hsu, Chia-Chun Tseng, Yu-Lin Lee, Chun-Eng Liu, Huey-Kang Sytwu
Publikováno v:
Biomedical Journal, Vol 43, Iss 4, Pp 314-317 (2020)
By the request of the Minister of Health and Welfare, NHRI Biobank was assigned to establish a COVID-19 biobank in early Feb, 2020 to collect COVID-19 patients’ blood samples for Taiwan researchers and industries in an emergent way. It was set up i
Externí odkaz:
https://doaj.org/article/fb3112a658cf4fa79aa30117009b7dc7
Autor:
Chuan-Pin Lin, Po-Cheng Liang, Ching-I Huang, Ming-Lun Yeh, Po-Yao Hsu, Cheng-Ting Hsu, Yu-Ju Wei, Ta-Wei Liu, Ming-Yen Hsieh, Nai-Jen Hou, Tyng-Yuang Jang, Yi-Hung Lin, Chih-Wen Wang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0245479 (2021)
Background/aimsUndetectable HCV RNA 12 weeks after the end of treatment (SVR12) has been the valid efficacy endpoint in the era of direct-acting antivirals (DAAs). Its concordance with SVR4 and SVR24 and long-term durability is unknown in Taiwanese c
Externí odkaz:
https://doaj.org/article/2e7b5d3bc7c343608fce8fbaecfe9598
Autor:
Chun-Ting Chen, Ming-Ying Lu, Meng-Hsuan Hsieh, Pei-Chien Tsai, Tsai-Yuan Hsieh, Ming-Lun Yeh, Ching-I Huang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Yu-Lueng Shih, Ming-Lung Yu
Publikováno v:
World Journal of Gastroenterology
BACKGROUND Prisoners are at risk of hepatitis C virus (HCV) infection, especially among the people who inject drugs (PWID). We implemented an outreach strategy in combination with universal mass screening and immediate onsite treatment with a simplif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35711ebceeb621e1975cb94b70dce1ce
http://europepmc.org/articles/PMC8776526
http://europepmc.org/articles/PMC8776526